Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay

Virology

Volumn 368, Issue 1, 2007, Pages 1-6

  Pontow, Suzanne ^a   Harmon, Brooke ^a   Campbell, Nancy ^a   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Envelope; Fusion; HIV 1; Rac

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR INHIBITOR; RAC PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FUSION GENE; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS;

CELL LINE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HIV FUSION INHIBITORS; HIV-1; HIV-2; HUMANS; RAC GTP-BINDING PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 35348983984     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.022     Document Type: Article

References (28)

1. Burridge K., and Wennerberg K. Rho and rac take center stage. Cell 116 2 (2004) 167-179
2. Cavrois M., Noronha C.D., and Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20 (2002) 1151-1154
3. Cavrois M., Neidleman J., Yonemoto W., Fenard D., and Greene W.C. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology 328 1 (2004) 36-44
4. Clavel F., and Charneau P. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68 2 (1994) 1179-1185
5. Derdeyn C.A., Decker J.M., Sfakianos J.N., Zhang Z., O'Brien W.A., Ratner L., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently moudlated by gp120 interactions with the coreceptor. J. Virol. 75 (2001) 8605-8614
6. Esser M.T., Mori T., Mondor I., Sattentau Q.J., Dey B., Berger E.A., Boyd M.R., and Lifson J.D. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73 5 (1999) 4360-4371
7. Freed E.O., and Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 (1996) 341-351
8. Gao Y., Dickerson J.B., Guo F., Zheng J., and Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. PNAS 101 20 (2004) 7618-7623
9. Hoppe S., Schelhaas M., Jaeger V., Liebig T., Petermann P., and Knebel-Morsdorf D. Early herpes simplex virus type 1 infection is dependent on regulated Rac1/Cdc42 signalling in epithelial MDCKII cells. J. Gen. Virol. 87 (2006) 3483-3494
10. Hung C.-S., Heyden N.V., and Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 73 (1999) 8216-8226
11. Janardhan A., Swigut T., Hill B., Myers M.P., and Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLOS 2 (2004) E6
12. Kaslow R.A., Ostrow D.G., Detels R., Phair J.P., and Rinaldo C.R. The Multicenter AIDS Cohort study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126 (1987) 310-318
13. Kaushik R., and Ratner L. Role of HIV-1 matrix phosphorylation in an early post-entry step of virus replication. J. Virol. 78 (2004) 2319-2326
14. Lakhe-Reddy S., Khan S., Konieczkowski M., Jarad G., Wu K.L., Reichardt L.F., Takai Y., Bruggeman L.A., Wang B., Sedor J.R., and Schelling J.R. Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation. J. Biol. Chem. 281 (2006) 19688-19699
15. Li E., Stupack D., Bokoch G.M., and Nemerow G.R. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72 (1998) 8806-8812
16. Matarrese P., and Malorni W. Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death. Cell Death Differ. 12 S1 (2005) 932-941
17. Murakami T., Ablan S., Freed E.O., and Tanaka Y. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J. Virol. 78 (2004) 1026-1031
18. Nussbaum O., Broder C.C., and Berger E.A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccina virus-based assay quantitating cell-fusion-dependent report gene activation. J. Virol. 68 (1994) 5411-5422
19. Pierson T.C., and Doms R.W. HIV-1 entry and its inhibition. Curr. Top. Microbiol. Immunol. 281 (2003) 1-27
20. Pirounaki M., vanderHeyden N.A., Arens M., and Ratner L. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line. J. Virol. Methods 85 (2000) 151-162
21. Pontow S., and Ratner L. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. J. Virol. 75 (2001) 11503-11514
22. Pontow S.E., Heyden N.V., Wei S., and Ratner L. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion. J. Virol. 78 (2004) 7138-7147
23. Pravecz T., and Norcross M.A. Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120. AIDS Res. Hum. Retrovir. 9 (1993) 945-955
24. Saeed M.F., Kolokoltsov A.A., and Davey R.A. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J. Virol. Methods 135 (2006) 143-150
25. Sodhi A., Montaner S., and Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat. Rev., Mol. Cell Biol. 5 (2004) 998-1012
26. Veettil M.V., Sharma-Walia N., Sadagopan S., Raghu H., Sivakumar R., Naranatt P.P., and Chandran B. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in an Src-dependent manner. J. Virol. 80 (2006) 11432-11446
27. Wu L., LaRosa G., Kassam N., Gordon C.J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J.P., and Mackay C.R. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186 8 (1997) 1373-1381
28. Yonezawa A., Cavrois M., and Greene W.C. Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J. Virol. 79 2 (2005) 918-926